BTB01303
BTB01303 is a (glutamate release) inhibitor. Cancer cells release high levels of (glutamate), which disrupts normal bone turnover and may lead to cancer-induced bone pain. BTB01303 has the potential to improve cancer-induced bone pain.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 652129-89-0
- Fòrmula: C15H11Cl2NO3
- Peso molecular:324.16
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
In Vitro
Chemical Information
-
No. CAS 652129-89-0
-
Peso molecular 324.16
-
Fòrmula C15H11Cl2NO3
-
SMILES
ClC1=CC(/C=N/C2=CC=C3OCOCC3=C2)=C(O)C(Cl)=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)